Eighth Amendment to Note Purchase Agreement Sample Contracts

EIGHTH AMENDMENT TO NOTE PURCHASE AGREEMENT AND FOURTH AMENDMENT TO DISCLOSURE LETTER
Eighth Amendment to Note Purchase Agreement • November 6th, 2025 • Puma Biotechnology, Inc. • Pharmaceutical preparations

This EIGHTH AMENDMENT TO NOTE PURCHASE AGREEMENT AND FOURTH AMENDMENT TO DISCLOSURE LETTER (this “Agreement”), dated as of October 6, 2025, is entered into by and among PUMA BIOTECHNOLOGY, INC., a Delaware corporation (the “Issuer”), the Guarantors party hereto, the Purchasers party hereto and ATHYRIUM OPPORTUNITIES IV CO-INVEST 1 LP, as the Administrative Agent. All capitalized terms used herein and not otherwise defined herein shall have the meanings given to such terms in the Note Purchase Agreement (as defined below).